Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Neonatal seizures linked to higher risk of epilepsy in children

Seizures in newborns are one of the most frequent acute neurological conditions among infants admitted to neonatal care units.

19 Feb 2025

Nerinetide shows promise in stroke treatment meta-analysis

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and Lancet Neurology-the ESCAPE-NEXT trial, the FRONTIER trial, and an individual patient-level meta-analysis across three trials.

19 Feb 2025

Drinking more water may lower heart disease risk, but too much coffee and tea could raise it

Drinking water may help reduce cardiovascular disease (CVD) risk, while excessive coffee and tea intake (≥6 cups/day) increases the likelihood of CVD, with stronger effects in women.

19 Feb 2025

Lower vitamin B12 levels could impact brain function in older adults

Meeting the minimum requirement for vitamin B12, needed to make DNA, red blood cells and nerve tissue, may not actually be enough – particularly if you are older. It may even put you at risk for cognitive impairment.

18 Feb 2025

UTHealth Houston launches at-home telerehabilitation trial for stroke patients in Rio Grande Valley

A new at-home telerehabilitation care service for stroke patients will be offered to residents of Cameron County in the Rio Grande Valley as part of a randomized clinical trial led by researchers from across UTHealth Houston.

18 Feb 2025

Study highlights risks of stopping anticoagulants in older patients

For patients with atrial fibrillation, the risk of stroke or heart attack from stopping anticoagulants usually outweighs the risk of bleeding, according to new findings from the University of Bath.

18 Feb 2025

American Heart Association launches preventive health initiative for CKM syndrome

Five regions in the U.S. have been selected to implement a new preventive health initiative to improve care for people with a cluster of chronic conditions known as cardiovascular-kidney-metabolic (CKM) syndrome.

18 Feb 2025

Combining social media posts and transformer-based learning models to detect heat stroke risks in Japan

Heat stroke poses a significant health risk, especially during extreme temperature conditions. As global temperatures rise due to climate change, the frequency and severity of heatwaves have increased, putting vulnerable populations at greater risk.

18 Feb 2025

New review maps the impact of reproductive hormones on neurological health

A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill University's Department of Neurology and Neurosurgery maps out the extensive influence of reproductive hormones on neurological health and disease.

18 Feb 2025

Fewer than 20% of women screened for cardiovascular risk after pregnancy complications

Less than one in five patients are tested for cardiovascular risk factors following pregnancy-related hypertension or diabetes, according to a new study published in the "Go Red for Women" issue of Circulation.

17 Feb 2025

ICHOM develops standard dataset that defines heart valve disease outcomes

The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of 16 patient-centered outcome measures for people with heart valve disease, regardless of treatment (surgical or transcatheter procedure), according to a new report published today in the American Heart Association's journal Circulation: Cardiovascular Quality & Outcomes.

17 Feb 2025

Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.

14 Feb 2025

UVA receives $9.3 million NIH grant for ketamine seizure treatment trial

University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to determine if the powerful anesthetic ketamine can save patients from prolonged, life-threatening grand mal seizures that won't respond to other treatments.

14 Feb 2025

Intracranial hemorrhages linked to higher dementia risk

Weill Cornell Medicine researchers have found that intracranial hemorrhages, or "brain bleeds" caused by a ruptured blood vessel in the brain, double a person's risk of developing dementia later in life.

14 Feb 2025

Researchers uncover cause of persistent blood clots despite treatment

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose blood thinners.

14 Feb 2025

Study identifies brain regions for speech production in aphasia patients

Imagine seeing a furry, four-legged animal that meows. Mentally, you know what it is, but the word "cat" is stuck on the tip of your tongue.

13 Feb 2025

Study suggests sun exposure during first year of life may reduce MS relapses

Getting at least 30 minutes of daily summer sun in the first year of life may mean a lower relapse risk for children who are diagnosed with multiple sclerosis (MS) later, according to a study published on February 12, 2025, online in Neurology® Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology.

13 Feb 2025

Epidural steroid injections may offer modest short-term pain relief for some back pain

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people with certain kinds of chronic back pain.

13 Feb 2025

Olpasiran significantly lowers "bad cholesterol" linked to cardiovascular risk

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai researcher of a phase 2 trial.

13 Feb 2025

Systemic racism may play a role in genetic testing disparities, study suggests

For children with signs of neurological conditions such as autism, epilepsy and global developmental delay, genetic testing can help make the diagnosis, identify possible treatments and determine whether family members could be affected, among other benefits.

13 Feb 2025